AlphaMadera's AlphaVal page classifies Stepan Co as a Stable Earnings Power business and values it using P/Adj-EPS × Normalized Multiple, then compares the result to the current market price to flag SCL as undervalued, fairly valued, or overvalued.

What is Stepan Co's fair value?

Fair value for SCL comes from a P/Adj-EPS × Normalized Multiple model -- the approach AlphaVal selected for this company's Stable Earnings Power classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value SCL?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. SCL was classified as Stable Earnings Power and is valued using P/Adj-EPS × Normalized Multiple, built from SCL's most recent reported fundamentals.

SCL - Stepan Co

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $85.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Mild

Trading 3.2% above fair value

Current Price $62.04

Bear Case $48.10 22.5% downside ($48.10 - $62.04) / $62.04 = -22.5% $4.01 × 12x P/E

Fair Value $60.12 3.1% downside ($60.12 - $62.04) / $62.04 = -3.1% $4.01 × 15x P/E

Bull Case $72.14 16.3% upside ($72.14 - $62.04) / $62.04 = 16.3% $4.01 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

4.01$

Key Value Driver

Normalized P/E multiple (15x base case)

Terminal Value % of EV

Implied Market Multiple 15.5x

Market is pricing in (growth)

Plain-Language Summary

Applying a 15x P/E to adjusted EPS of $4.01, the base-case value is $60.12 per share. DDM cross-check: $35.12.

Warnings

⚠ The company's reported profits differ from official accounting profits by 96%. Check what costs are being left out of the adjusted number.

ℹ Dividend-based valuation: $35.12 (below our primary estimate by 42%). Large gaps may signal the dividend doesn't reflect full earning power.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples